Matches in Wikidata for { <http://www.wikidata.org/entity/Q79162998> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q79162998 description "article scientifique publié en 2003" @default.
- Q79162998 description "artículu científicu espublizáu n'ochobre de 2003" @default.
- Q79162998 description "im Oktober 2003 veröffentlichter wissenschaftlicher Artikel" @default.
- Q79162998 description "scientific article published on 01 October 2003" @default.
- Q79162998 description "wetenschappelijk artikel" @default.
- Q79162998 description "наукова стаття, опублікована в жовтні 2003" @default.
- Q79162998 description "مقالة علمية تنشرت ف 1 أكتوبر 2003" @default.
- Q79162998 name "Monitoring by rheumatologists for methotrexate-, etanercept-, infliximab-, and anakinra-associated adverse events" @default.
- Q79162998 name "Monitoring by rheumatologists for methotrexate-, etanercept-, infliximab-, and anakinra-associated adverse events" @default.
- Q79162998 type Item @default.
- Q79162998 label "Monitoring by rheumatologists for methotrexate-, etanercept-, infliximab-, and anakinra-associated adverse events" @default.
- Q79162998 label "Monitoring by rheumatologists for methotrexate-, etanercept-, infliximab-, and anakinra-associated adverse events" @default.
- Q79162998 prefLabel "Monitoring by rheumatologists for methotrexate-, etanercept-, infliximab-, and anakinra-associated adverse events" @default.
- Q79162998 prefLabel "Monitoring by rheumatologists for methotrexate-, etanercept-, infliximab-, and anakinra-associated adverse events" @default.
- Q79162998 P1433 Q79162998-09E7858C-5BFD-4F26-8712-B3BA41BBE3C7 @default.
- Q79162998 P1476 Q79162998-8E1D7933-4D62-4D06-A3BC-49AED29B9B83 @default.
- Q79162998 P2093 Q79162998-70474DB7-1470-4FDE-875C-7D7F9E6B0885 @default.
- Q79162998 P2093 Q79162998-A872C176-0D61-4084-A231-B4CAF465D695 @default.
- Q79162998 P2093 Q79162998-B65CA154-5449-4400-9479-8F71073F271C @default.
- Q79162998 P304 Q79162998-26814896-9178-407A-8B66-8E554563E286 @default.
- Q79162998 P31 Q79162998-92B8E951-CECE-4114-9EBC-F02AD9ADB72C @default.
- Q79162998 P356 Q79162998-AB432CFC-C9BD-4473-8A11-0FC89A2666D2 @default.
- Q79162998 P433 Q79162998-717DE5B6-0A1A-44AB-99CC-1C097464C029 @default.
- Q79162998 P478 Q79162998-D4B175D7-02A5-4914-93A2-8762EAF302AF @default.
- Q79162998 P577 Q79162998-61420A9E-A8FD-439C-861F-FA323C9B2CB7 @default.
- Q79162998 P698 Q79162998-30247C9C-FC9B-43E4-8756-2EDB3304EC13 @default.
- Q79162998 P356 ART.11277 @default.
- Q79162998 P698 14558081 @default.
- Q79162998 P1433 Q23929027 @default.
- Q79162998 P1476 "Monitoring by rheumatologists for methotrexate-, etanercept-, infliximab-, and anakinra-associated adverse events" @default.
- Q79162998 P2093 "Doruk Erkan" @default.
- Q79162998 P2093 "Stephen A Paget" @default.
- Q79162998 P2093 "Yusuf Yazici" @default.
- Q79162998 P304 "2769-2772" @default.
- Q79162998 P31 Q13442814 @default.
- Q79162998 P356 "10.1002/ART.11277" @default.
- Q79162998 P433 "10" @default.
- Q79162998 P478 "48" @default.
- Q79162998 P577 "2003-10-01T00:00:00Z" @default.
- Q79162998 P698 "14558081" @default.